The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes
J Deng, L Peng, G Zhang, X Lan, C Li, F Chen…
Index: Deng, Jifeng; Peng, Li; Zhang, Guicheng; Lan, Xiaobing; Li, Chufang; Chen, Fuxin; Zhou, Yayao; Lin, Zuoxian; Chen, Ling; Dai, Renke; Xu, Hongjiang; Yang, Ling; Zhang, Xiquan; Hu, Wenhui European Journal of Medicinal Chemistry, 2011 , vol. 46, # 1 p. 71 - 76
Full Text: HTML
Citation Number: 28
Abstract
New dipeptidyl peptidase IV inhibitors were designed based on Alogliptin using a scaffold- hopping strategy. All of the compounds constructed on a thienopyrimidine scaffold demonstrated good inhibition and selectivity for DPP-IV. Compound 10d exhibited subnanomolar (IC50= 0.33 nM) DPP-IV inhibitory activity, good in vivo efficacy and an acceptable pharmacokinetic profile. A pharmacokinetic-driven optimization of 10d may ...
Related Articles:
[Venskutonyte, Raminta; Butini, Stefania; Sanna Coccone, Salvatore; Gemma, Sandra; Brindisi, Margherita; Kumar, Vinod; Guarino, Egeria; Maramai, Samuele; Valenti, Salvatore; Amir, Ahmad; Valades, Elena Anton; Frydenvang, Karla; Kastrup, Jette S.; Novellino, Ettore; Campiani, Giuseppe; Pickering, Darryl S. Journal of Medicinal Chemistry, 2011 , vol. 54, # 13 p. 4793 - 4805]
[Son, Hoon Young; Song, Yang-Heon Bulletin of the Korean Chemical Society, 2010 , vol. 31, # 8 p. 2242 - 2246]
[Journal of Medicinal Chemistry, , vol. 54, # 22 p. 7815 - 7833]